Sprout BioVentures
3
5M
2
2
0.33
- Stages of investment
- Areas of investment
Summary
The standard case for the fund is to invest in rounds with 3 partakers. Despite the Sprout BioVentures, startups are often financed by BioAdvance. The meaningful sponsors for the fund in investment in the same round are Viva Biotech, Viva BioInnovator, Lumira Ventures.
Among the most popular fund investment industries, there are Software, Gaming. Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund. Among the various public portfolio startups of the fund, we may underline Mebias Discovery
The common things for fund are deals in the range of 1 - 5 millions dollars. The high activity for fund was in 2019. The fund is constantly included in 2-6 deals per year.
Investments analytics
Analytics
- Total investments
- 3
- Lead investments
- 2
- Follow on index
- 0.33
- Investments by industry
- Biotechnology (2)
- Biopharma (2)
- Therapeutics (2)
- iOS (1)
- Gaming (1)
- Investments by region
-
- Canada (2)
- United States (1)
- Peak activity year
- 2019
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 8
- Group Appearance index
- 1.00
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| AmacaThera | 22 Feb 2021 | Biotechnology, Therapeutics, Biopharma | Early Stage Venture | 10M | Ontario, Old Toronto, Canada |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.